143 related articles for article (PubMed ID: 29100336)
21. Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer.
Dey P; Velazquez-Villegas LA; Faria M; Turner A; Jonsson P; Webb P; Williams C; Gustafsson JÅ; Ström AM
PLoS One; 2015; 10(5):e0128239. PubMed ID: 26010887
[TBL] [Abstract][Full Text] [Related]
22. ERβ Isoforms Have Differential Clinical Significance in Breast Cancer Subtypes and Subgroups.
Choi Y; Kim H; Pollack S
Curr Issues Mol Biol; 2022 Apr; 44(4):1564-1586. PubMed ID: 35723365
[TBL] [Abstract][Full Text] [Related]
23. Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.
Yehia L; Boulos F; Jabbour M; Mahfoud Z; Fakhruddin N; El-Sabban M
PLoS One; 2015; 10(6):e0129356. PubMed ID: 26046764
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of estrogen receptor proteins in rat ovary.
Sakaguchi H; Fujimoto J; Hong BL; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):83-91. PubMed ID: 15862953
[TBL] [Abstract][Full Text] [Related]
25. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
[TBL] [Abstract][Full Text] [Related]
26. Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1α and pyruvate kinase M2.
Chu X; Xiang M; Feng L; Liu H; Zhou C
J Thorac Dis; 2019 Sep; 11(9):3941-3950. PubMed ID: 31656668
[TBL] [Abstract][Full Text] [Related]
27. The potential role of estrogen receptor β2 in breast cancer.
Baek JM; Chae BJ; Song BJ; Jung SS
Int J Surg; 2015 Feb; 14():17-22. PubMed ID: 25450264
[TBL] [Abstract][Full Text] [Related]
28. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
29. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
[TBL] [Abstract][Full Text] [Related]
30. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.
Skliris GP; Leygue E; Curtis-Snell L; Watson PH; Murphy LC
Br J Cancer; 2006 Sep; 95(5):616-26. PubMed ID: 16880783
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II differentially regulates Morg1 expression in kidney cells.
Bondeva T; Heinzig J; Franke S; Wolf G
Am J Nephrol; 2012; 35(5):442-55. PubMed ID: 22555025
[TBL] [Abstract][Full Text] [Related]
32. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
33. Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.
Liu J; Sareddy GR; Zhou M; Viswanadhapalli S; Li X; Lai Z; Tekmal RR; Brenner A; Vadlamudi RK
Cancer Res; 2018 Jun; 78(12):3176-3189. PubMed ID: 29661831
[TBL] [Abstract][Full Text] [Related]
34. ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.
Bado I; Nikolos F; Rajapaksa G; Gustafsson JÅ; Thomas C
Oncotarget; 2016 Mar; 7(12):13599-611. PubMed ID: 26871946
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7.
Omoto Y; Eguchi H; Yamamoto-Yamaguchi Y; Hayashi S
Oncogene; 2003 Aug; 22(32):5011-20. PubMed ID: 12902984
[TBL] [Abstract][Full Text] [Related]
36. Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC).
Oturkar CC; Gandhi N; Rao P; Eng KH; Miller A; Singh PK; Zsiros E; Odunsi KO; Das GM
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267428
[TBL] [Abstract][Full Text] [Related]
37. Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer.
Hamilton N; Márquez-Garbán D; Mah V; Fernando G; Elshimali Y; Garbán H; Elashoff D; Vadgama J; Goodglick L; Pietras R
Biomed Res Int; 2015; 2015():925703. PubMed ID: 25874233
[TBL] [Abstract][Full Text] [Related]
38. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates.
Wong NA; Malcomson RD; Jodrell DI; Groome NP; Harrison DJ; Saunders PT
J Pathol; 2005 Sep; 207(1):53-60. PubMed ID: 15954165
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II induces hypoxia-inducible factor-1 alpha in PC 12 cells through a posttranscriptional mechanism: role of AT2 receptors.
Wolf G; Schroeder R; Stahl RA
Am J Nephrol; 2004; 24(4):415-21. PubMed ID: 15308873
[TBL] [Abstract][Full Text] [Related]
40. ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.
Wang J; Zhang C; Chen K; Tang H; Tang J; Song C; Xie X
Breast Cancer Res Treat; 2015 Jul; 152(2):255-69. PubMed ID: 26070269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
